Cambridge Investment Research Advisors »

Prime Medicine shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $43k 12k 3.49

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Microsoft Corp Com (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
SPDR Gold Tr Gold Shs (GLD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
ARK Investment Management
T. Rowe Price Investment Management
State Street Corporation
Vanguard Capital Management
Balyasny Asset Management
Casdin Capital
Woodline Partners
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Geode Capital Management
FMR

View all funds holding Prime Medicine